Search peptides, terms, sources/
Regulatory source · 2025

PMDA medicinal product information: GHRP Kaken 100 Injection (pralmorelin hydrochloride), package insert

About this source

Kind
Regulatory or official document
Primary or secondary
primary
Peer review
not peer reviewed
Retraction status
None known
Date checked
14 November 2026

Limitations

A Japanese-language regulator record. It shows the authorised indication (diagnosis of growth hormone secretion deficiency), the approval number (21600AMZ00573) and the marketing start (February 2005). The page fetched does not state the approval date. It says nothing about UK or EU status and is not evidence of benefit.

Cited in

Spotted an error? Report a problem with this page. We correct the record and log every change on What's changed.